NK

Naresh Kumar Goel

Active Director Director DIN 00376267
DIN 00376267 First appointment Mar 1999 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 9 active board seats
Past companies 7 historical roles
Total affiliations 16 Since Mar 1999
Shareholding value β€’β€’β€’β€’ Premium profile
Directorship timeline
First appointment 12 Mar 1999
Active appointments 10
Total timeline records 16

Naresh Kumar Goel (DIN 00376267) has 16 recorded board appointments in Indian companies, the first from March 1999, of which 10 are current. The chart and the list below show each company, the role held and the years of the appointment, as filed with the Ministry of Corporate Affairs.

Appointment history

Since 1999
Cogni Pharmaceuticals Llp Partner · 2026 – present
Current
Sun Medilab Llp Designated Partner · 2025 – present
Current
Warner India Lifesciences Limited Director · 2022 – present
Current
Cogni Labs Limited Director · 2016 – present
Current
Austro Labs Limited Director · 2014 – present
Current
Sentosa Geigy (India) Labs Limited Director · 2010 – present
Current
Sun Medilab Private Limited Director · 2007 – present
Current
Recova Pharma Expo Private Limited Director · 2006 – present
Current
Shrish Enterprises Private Limited Director · 2000 – present
Current
Gangesh Pharma Private Limited Director · 1999 – present
Current
Infar Healthcare Private Limited Director · 2010 – 2014
Previous
Helax Probic Private Limited Director · 2009 – 2012
Previous
Astra Medica Private Limited Director · 2009 – 2014
Previous
Medial Pharma Limited Director · 2008 – 2014
Previous
Warner (India) Pharma Private Limited Director · 2007 – 2010
Previous
Knoll Pharmaceuticals Limited Director · 2005 – 2011
Previous

Interactive timeline

Hover bars for tenure details
Loading chart...
Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available